at seekingalpha.com (Tue, 10-Nov 9:10 AM)
Immatics Reports Third-Quarter 2026 Results and Business Update
at www.tipranks.com (Tue, 10-Nov 7:28 AM)
Immatics’ $150 Million Underwritten Offering Set to Fuel PRAME-Targeted Cancer Therapies
Market Chameleon (Tue, 25-Aug 9:15 AM)
